Download PDFPDF
Autoinflammatory gene mutations in Behçet’s disease
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Henoch Schönlein Purpura is not associated with mutations in Mevalonate Kinase gene.
    • Alessandra Pontillo, Biologist
    • Other Contributors:
      • Martina Girardelli, Alberto Tommasini, Javier Martín, Miguel A. Gonzalez-Gay, Alessandra Pontillo.

    Dear Editor,

    The issue that mutations in genes responsible for autoinflammatory syndromes could explain also some inflammatory or rheumatological disorders has been raised in recent researches. In particular, Mevalonate Kinase Deficiency (MKD) can occasionally overlap clinically and genetically with Behcet's disease. A clinical overlap could be observed also between episodes of MKD and Henoch Schönlein Purpura (HSP):...

    Show More
    Conflict of Interest:
    None declared.